[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01GA01, streptomycin, Telavancin may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01CG01, sulbactam, Telavancin may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Telavancin.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Telavancin.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Telavancin.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L02BA01, tamoxifen, The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Telavancin.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Telavancin.]
[B01AE07, dabigatran etexilate, Telavancin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Tetracaine.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AE05, lurasidone, The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Telavancin.]
[N04BC07, apomorphine, The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Telavancin.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Telavancin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Telavancin.]
[G04BE06, moxisylyte, Telavancin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Telavancin may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01ED01, timolol, The risk or severity of QTc prolongation can be increased when Timolol is combined with Telavancin.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01AA12, tobramycin, Telavancin may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Telavancin.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Telavancin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A03AA05, trimebutine, The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Telavancin.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Telavancin.]
[N03AC02, trimethadione, The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Telavancin.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AA06, trimipramine, The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Telavancin.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Telavancin.]
[R03DX07, roflumilast, Roflumilast may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Vandetanib.]
[R02AA14, oxyquinoline, Telavancin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[J05AG05, rilpivirine, The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Telavancin.]
[S01AA28, vancomycin, Telavancin may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Telavancin.]
[B01AF01, rivaroxaban, Rivaroxaban may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Telavancin.]
[C08DA01, verapamil, Verapamil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AX09, viloxazine, Telavancin may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B01AA03, warfarin, Telavancin may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Zuclopenthixol.]
[L01EC01, vemurafenib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01ED01, crizotinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Crizotinib.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Telavancin.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Telavancin may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Telavancin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Telavancin.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J02AC03, voriconazole, The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Telavancin.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Atropine is combined with Telavancin.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B03XA04, peginesatide, Telavancin may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A08AA11, lorcaserin, Lorcaserin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[G04BD12, mirabegron, The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Telavancin.]
[L02BB04, enzalutamide, Telavancin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[D02BA02, octinoxate, Telavancin may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Telavancin.]
[N04BD02, rasagiline, Rasagiline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V09IX04, fluorodeoxyglucose F18, Telavancin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Telavancin.]
[V08CA11, gadofosveset, Telavancin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Telavancin may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Bedaquiline.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Telavancin.]
[A10BH04, alogliptin, Alogliptin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Telavancin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Telavancin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Telavancin.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Telavancin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Benzocaine.]
[L03AA12, ancestim, Telavancin may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Telavancin.]
[L01EC02, dabrafenib, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Telavancin.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EE01, trametinib, Telavancin may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Telavancin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Telavancin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Bepridil.]
[A10BJ03, lixisenatide, Telavancin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Telavancin may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Telavancin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AP08, sofosbuvir, Telavancin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05CH03, tasimelteon, Telavancin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Apremilast may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L02BG02, formestane, Telavancin may decrease the excretion rate of Formestane which could result in a higher serum level.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01ED02, ceritinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ceritinib.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Telavancin.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Telavancin is combined with Acenocoumarol.]
[R03AC19, olodaterol, The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Telavancin.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A16AX10, eliglustat, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Eliglustat.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S03AA06, gentamicin, Telavancin may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Telavancin is combined with Dicoumarol.]
[B01AF03, edoxaban, Telavancin may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Telavancin.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Lenvatinib.]
[L01XH03, panobinostat, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Panobinostat.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Telavancin is combined with Tioclomarol.]
[C01EB17, ivabradine, Ivabradine may increase the QTc-prolonging activities of Telavancin.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB37, idarucizumab, Telavancin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Telavancin.]
[L01XG03, ixazomib, Telavancin may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[G04CA01, alfuzosin, The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Telavancin.]
[M04AB05, lesinurad, Telavancin may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N03AX23, brivaracetam, Brivaracetam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05BA08, bromazepam, Bromazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Telavancin may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Telavancin.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Telavancin.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Telavancin.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Arsenic trioxide.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Artemether.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Telavancin.]
[S01AA26, azithromycin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Telavancin.]
[L01EF02, ribociclib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A06AH05, naldemedine, Telavancin may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Telavancin.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Telavancin may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N07XX13, valbenazine, Telavancin may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Telavancin.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Telavancin.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AG03, efavirenz, The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Telavancin.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Budesonide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Telavancin.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Telavancin.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Macimorelin.]
[L02BB05, apalutamide, Telavancin may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Telavancin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Telavancin.]
[L04AA37, baricitinib, Telavancin may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Encorafenib.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01GB14, plazomicin, Telavancin may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Telavancin.]
[L01XX62, ivosidenib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ivosidenib.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N03AX17, stiripentol, Telavancin may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Telavancin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Telavancin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Telavancin.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Gilteritinib.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Amifampridine.]
[A06AX05, prucalopride, Telavancin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Telavancin.]
[B01AC23, cilostazol, The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Telavancin.]
[P02BX04, triclabendazole, The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Telavancin.]
[J01FA09, clarithromycin, The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Telavancin.]
[N06BA14, solriamfetol, Telavancin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Entrectinib.]
[N07XX11, pitolisant, Telavancin may increase the QTc-prolonging activities of Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Telavancin.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M09AX08, golodirsen, Telavancin may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Telavancin.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Dexchlorpheniramine.]
[S01XA12, dexpanthenol, Telavancin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Telavancin.]
[R02AA03, dichlorobenzyl alcohol, Telavancin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Telavancin may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C08CA16, clevidipine, Clevidipine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BD07, dronedarone, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Dronedarone.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Telavancin.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V08CA05, mangafodipir, Telavancin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Dyclonine.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Ebastine is combined with Telavancin.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Telavancin.]
[P01BA01, chloroquine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Telavancin.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Telavancin.]
[N05AA01, chlorpromazine, The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Telavancin.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Telavancin.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02BA03, choline salicylate, Telavancin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B06AC06, berotralstat, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Berotralstat.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Relugolix is combined with Telavancin.]
[M01AX25, chondroitin sulfates, Telavancin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[N03AX10, felbamate, The risk or severity of QTc prolongation can be increased when Felbamate is combined with Telavancin.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Flumequine is combined with Telavancin.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02BG07, flupirtine, Telavancin may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The risk or severity of QTc prolongation can be increased when Formoterol is combined with Telavancin.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Telavancin.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N07CA02, cinnarizine, The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Telavancin.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Telavancin.]
[S03AA07, ciprofloxacin, The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Telavancin.]
[L01XA01, cisplatin, Telavancin may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Telavancin is combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Mobocertinib.]
[V09AB03, ioflupane I-123, Telavancin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Telavancin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Telavancin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Clemastine.]
[J04BA01, clofazimine, The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Telavancin.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The risk or severity of QTc prolongation can be increased when Pacritinib is combined with Telavancin.]
[N06AA04, clomipramine, The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Telavancin.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[A04AA01, ondansetron, The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Telavancin.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Granisetron is combined with Telavancin.]
[N05AH02, clozapine, The risk or severity of QTc prolongation can be increased when Clozapine is combined with Telavancin.]
[J01GB12, arbekacin, Telavancin may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Cocaine.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M04AC01, colchicine, Colchicine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01XB01, colistin, Telavancin may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Desflurane is combined with Telavancin.]
[A04AA03, tropisetron, Telavancin may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01FA15, telithromycin, The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Telavancin.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Telavancin.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C05BB03, invert sugar, Telavancin may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V08AB05, iopromide, Telavancin may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Telavancin may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Telavancin may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J02AC02, itraconazole, The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Telavancin.]
[B01AB12, bemiparin, The therapeutic efficacy of Bemiparin can be decreased when used in combination with Telavancin.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Emedastine is combined with Telavancin.]
[N05BA10, ketazolam, Ketazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA01, imatinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Imatinib.]
[J02AC04, posaconazole, The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Telavancin.]
[C08CA09, lacidipine, The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Telavancin.]
[N03AX09, lamotrigine, The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Telavancin.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Telavancin.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Telavancin.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Telavancin.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Telavancin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[R06AD07, mequitazine, The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Telavancin.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Adenosine is combined with Telavancin.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Telavancin.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Telavancin.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Telavancin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE09, vardenafil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Telavancin.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N07BB05, nalmefene, Nalmefene may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01DX16, nicorandil, Telavancin may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M03AC11, cisatracurium, Telavancin may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AB10, escitalopram, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Telavancin.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AA01, desipramine, The risk or severity of QTc prolongation can be increased when Desipramine is combined with Telavancin.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V04CH02, indigo carmine, Telavancin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Telavancin.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Cinchocaine.]
[R05DA08, pholcodine, Telavancin may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Telavancin.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Telavancin.]
[L01EB02, erlotinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Erlotinib.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, The risk or severity of QTc prolongation can be increased when Isradipine is combined with Telavancin.]
[D07XC04, diflucortolone, Telavancin may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01AA04, digitoxin, The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Telavancin.]
[C01AA05, digoxin, Telavancin may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AE08, atazanavir, The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Telavancin.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Telavancin.]
[H03BC01, potassium perchlorate, Telavancin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Pramocaine.]
[C08DB01, diltiazem, The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Telavancin.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Telavancin.]
[V03AB09, dimercaprol, Telavancin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Dimethyl sulfoxide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Diphenhydramine.]
[A03FA02, cisapride, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Cisapride.]
[S01AX06, resorcinol, Telavancin may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Disopyramide.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Telavancin.]
[N05AX08, risperidone, The risk or severity of QTc prolongation can be increased when Risperidone is combined with Telavancin.]
[R06AE09, levocetirizine, The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Telavancin.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Telavancin.]
[L01EX01, sunitinib, The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Telavancin.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Telavancin.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01EB18, ranolazine, The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Telavancin.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R03AC12, salmeterol, The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Telavancin.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A03FA03, domperidone, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Domperidone.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AA16, dothiepin, The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Telavancin.]
[N06AA12, doxepin, The risk or severity of QTc prolongation can be increased when Doxepin is combined with Telavancin.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Telavancin.]
[N01AB08, sevoflurane, The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Telavancin.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Telavancin.]
[A08AA10, sibutramine, Sibutramine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A12CA02, sodium sulfate, Telavancin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Sultopride.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C07AB13, talinolol, The risk or severity of QTc prolongation can be increased when Talinolol is combined with Telavancin.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Temafloxacin.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Terodiline.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AG03, toloxatone, Telavancin may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Telavancin.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Toremifene.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Chloral hydrate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Telavancin.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Telavancin.]
[S01GX10, epinastine, The risk or severity of QTc prolongation can be increased when Epinastine is combined with Telavancin.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BG01, moricizine, The risk or severity of QTc prolongation can be increased when Moricizine is combined with Telavancin.]
[N03AG01, valproic acid, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Valproic acid.]
[L03AX05, pidotimod, Telavancin may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Telavancin.]
[N05CD04, estazolam, Estazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ibutilide.]
[N03AD01, ethosuximide, The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Telavancin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Telavancin.]
[L04AD02, tacrolimus, The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Telavancin.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Telavancin.]
[R06AX11, astemizole, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Astemizole.]
[R06AX12, terfenadine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Terfenadine.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Encainide is combined with Telavancin.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Telavancin.]
[B05AA05, dextran, Telavancin may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Famotidine is combined with Telavancin.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C08CA02, felodipine, The risk or severity of QTc prolongation can be increased when Felodipine is combined with Telavancin.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Fendiline.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Telavancin.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[G04BD02, flavoxate, Flavoxate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BC04, flecainide, The risk or severity of QTc prolongation can be increased when Flecainide is combined with Telavancin.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J02AC01, fluconazole, The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Telavancin.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01BC02, fluorouracil, The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Telavancin.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Telavancin.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Flupentixol.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AG01, fluspirilene, The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Telavancin.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01BC03, tegafur, Telavancin may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Amisulpride.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Telavancin.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Telavancin.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C10AB04, gemfibrozil, Gemfibrozil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Telavancin.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Telavancin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Telavancin.]
[L01EA02, dasatinib, The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Telavancin.]
[N03AD03, methsuximide, The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Telavancin.]
[L01EH01, lapatinib, The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Telavancin.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Dofetilide.]
[L01EX02, sorafenib, The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Telavancin.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Telavancin.]
[M01CB04, aurothioglucose, Telavancin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Telavancin is combined with Fluindione.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Telavancin.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Haloperidol.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Telavancin.]
[N05AH04, quetiapine, The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Telavancin.]
[N06BX13, idebenone, Telavancin may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C09CA01, losartan, The risk or severity of QTc prolongation can be increased when Losartan is combined with Telavancin.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be decreased when used in combination with Telavancin.]
[G03DC01, allylestrenol, Allylestrenol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C08CA10, nilvadipine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Oxatomide.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C02DB02, hydralazine, Hydralazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Telavancin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[G04BD06, propiverine, Telavancin may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[P01BA02, hydroxychloroquine, The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Telavancin.]
[B05AA07, hetastarch, Telavancin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Hydroxyzine.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B05XA08, sodium acetate, Telavancin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Ifosfamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AA02, imipramine, The risk or severity of QTc prolongation can be increased when Imipramine is combined with Telavancin.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Telavancin.]
[R01AD07, tixocortol, Telavancin may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Telavancin.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A11HA07, inositol, Telavancin may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Milnacipran may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Articaine.]
[A10BH01, sitagliptin, Sitagliptin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Telavancin.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Anagrelide.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Telavancin may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N01AB06, isoflurane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Telavancin.]
[J04AC01, isoniazid, Isoniazid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AX05, inosine pranobex, Telavancin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01AA24, kanamycin, Telavancin may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Ketamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B01AC22, prasugrel, Prasugrel may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J02AB02, ketoconazole, The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Telavancin.]
[N05AH03, olanzapine, The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Telavancin.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Mizolastine.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Telavancin.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Telavancin.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Telavancin.]
[S01AA21, amikacin, Telavancin may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA03, loperamide, The risk or severity of QTc prolongation can be increased when Loperamide is combined with Telavancin.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B05XA11, magnesium chloride, Telavancin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Telavancin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Telavancin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Telavancin.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Telavancin.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The therapeutic efficacy of Nadroparin can be decreased when used in combination with Telavancin.]
[B01AB05, enoxaparin, The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Telavancin.]
[B01AB04, dalteparin, The therapeutic efficacy of Dalteparin can be decreased when used in combination with Telavancin.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Mepivacaine.]
[G04BX16, tiopronin, Telavancin may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Telavancin.]
[N05AX13, paliperidone, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Paliperidone.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Telavancin.]
[N07BC02, methadone, The risk or severity of QTc prolongation can be increased when Methadone is combined with Telavancin.]
[N06BA03, methamphetamine, Metamfetamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01BA04, pemetrexed, Telavancin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AA02, methotrimeprazine, The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Telavancin.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V04CG05, methylene blue, Telavancin may decrease the excretion rate of Methylene blue which could result in a higher serum level.]
[G03EK01, methyltestosterone, Telavancin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Telavancin.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[P01AB01, metronidazole, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Telavancin.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B01AB07, parnaparin, The therapeutic efficacy of Parnaparin can be decreased when used in combination with Telavancin.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[G03XB01, mifepristone, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Mifepristone.]
[B01AB10, tinzaparin, The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Telavancin.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BD01, amiodarone, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Telavancin.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Telavancin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Telavancin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Pazopanib.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Telavancin.]
[N06AA17, amoxapine, The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Telavancin.]
[C07AA12, nadolol, Nadolol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[V03AB15, naloxone, Naloxone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S03AA01, neomycin, Telavancin may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Telavancin.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AX14, iloperidone, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Iloperidone.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L03AX16, plerixafor, Telavancin may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Telavancin may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Telavancin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C08CA04, nicardipine, The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Telavancin.]
[C08CA05, nifedipine, The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Telavancin.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C08CA06, nimodipine, The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Telavancin.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Telavancin.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Telavancin.]
[N06AA10, nortriptyline, The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Telavancin.]
[B01AB08, reviparin, The therapeutic efficacy of Reviparin can be decreased when used in combination with Telavancin.]
[H01CB02, octreotide, The risk or severity of QTc prolongation can be increased when Octreotide is combined with Telavancin.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Telavancin.]
[N02AA02, opium, Telavancin may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Telavancin.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Telavancin.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Asenapine.]
[B01AB09, danaparoid, The therapeutic efficacy of Danaparoid can be decreased when used in combination with Telavancin.]
[J04AB30, capreomycin, Telavancin may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Papaverine is combined with Telavancin.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Telavancin.]
[G04BD11, fesoterodine, Telavancin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Penbutolol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AG03, penfluridol, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Penfluridol.]
[J01CE09, penicillin G procaine, Telavancin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01XX08, pentostatin, Telavancin may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C08EX02, perhexiline, The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Telavancin.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Telavancin is combined with Phenindione.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Telavancin.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Telavancin is combined with Phenprocoumon.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Telavancin.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C08CX01, mibefradil, The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Telavancin.]
[N05AG02, pimozide, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Pimozide.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AE01, saquinavir, The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Telavancin.]
[N06BX03, piracetam, Telavancin may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Grepafloxacin.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Telavancin.]
[A10BH03, saxagliptin, Saxagliptin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Telavancin.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Antazoline.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Telavancin.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of QTc prolongation can be increased when Primaquine is combined with Telavancin.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Probucol is combined with Telavancin.]
[C01BA02, procainamide, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Procainamide.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Procaine.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Telavancin.]
[N05AA03, promazine, The risk or severity of QTc prolongation can be increased when Promazine is combined with Telavancin.]
[R06AD02, promethazine, The risk or severity of QTc prolongation can be increased when Promethazine is combined with Telavancin.]
[C01BC03, propafenone, The risk or severity of QTc prolongation can be increased when Propafenone is combined with Telavancin.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01XH02, romidepsin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Romidepsin.]
[N01AX10, propofol, The risk or severity of QTc prolongation can be increased when Propofol is combined with Telavancin.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[B01AC09, epoprostenol, Epoprostenol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Telavancin.]
[N05AX12, aripiprazole, The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Telavancin.]
[N07XX07, dalfampridine, Telavancin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Telavancin may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[R06AC01, pyrilamine, The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Telavancin.]
[C01BA01, quinidine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Quinidine.]
[P01BC01, quinine, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Quinine.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Telavancin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J01GB08, sisomicin, Telavancin may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Telavancin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Sotalol.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.]
